Hemophilia Resources

Hemophilia is usually an inherited bleeding disorder in which the blood does not clot properly. This can lead to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains many proteins called clotting factors that can help to stop bleeding. People with hemophilia have low levels of either factor VIII (8) or factor IX (9). The severity of hemophilia that a person has is determined by the amount of factor in the blood. The lower the amount of the factor, the more likely it is that bleeding will occur which can lead to serious health problems.¹ AMCP is pleased to offer these resources to you from our Market Insights Summit on Hemophilia. 

AMCP Market Insights Summit: Hemophilia

Program 1

• Proceedings:
  Summit on Hemophilia: Findings from the AMCP Market Insights Program

• Webinar:
  Understanding Hemophilia Patient Management and Reimbursement — Proceedings from the 2018 AMCP Market Insights Program

Program 2

• Proceedings: 
  Summit on the Future Treatments in Hemophilia: Findings from the AMCP Market Insights Program

• Webinar:
  Future of Hemophilia Treatments — Impact on Payers

_{1. Centers for Disease Control and Prevention. (n.d.). Hemophilia. Retrieved from: https://www.cdc.gov/ncbddd/hemophilia/facts.html}